−305KRW
−5.51 BKRW
9.76 BKRW
12.30 M
About GENOLUTION
Sector
Industry
CEO
Ki-Ok Kim
Website
Headquarters
Seoul
Employees (FY)
82
Founded
2006
ISIN
KR7225220003
FIGI
BBG009Q078R7
GENOLUTION, Inc. engages in the research and development of nucleic acid extractors. It operates through the Vitro Diagnostic and RNAi business divisions. The company was founded on February 20, 2006 and is headquartered in Seoul, South Korea.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of 225220 is 3960 KRW — it has decreased by 0.25% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on KRX exchange GENOLUTION stocks are traded under the ticker 225220.
225220 stock is 2.15% volatile and has beta coefficient of 0.27. Check out the list of the most volatile stocks — is GENOLUTION there?
GENOLUTION revenue for the last quarter amounts to 28.20 B KRW despite the estimated figure of 23.20 B KRW. In the next quarter revenue is expected to reach 37.40 B KRW.
Yes, you can track GENOLUTION financials in yearly and quarterly reports right on TradingView.
225220 stock has risen by 4.07% compared to the previous week, the month change is a 3.13% rise, over the last year GENOLUTION has showed a 28.78% decrease.
225220 net income for the last quarter is −4.15 B KRW, while the quarter before that showed −389.79 M KRW of net income which accounts for −964.05% change. Track more GENOLUTION financial stats to get the full picture.
Today GENOLUTION has the market capitalization of 71.68 B, it has increased by 5.16% over the last week.
Like other stocks, 225220 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade GENOLUTION stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 29, 2024, the company has 82.00 employees. See our rating of the largest employees — is GENOLUTION on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So GENOLUTION technincal analysis shows the buy rating today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating GENOLUTION stock shows the sell signal. See more of GENOLUTION technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. GENOLUTION EBITDA is −5.51 B KRW, and current EBITDA margin is −56.48%. See more stats in GENOLUTION financial statements.